Ryzolt available for moderate to moderately severe chronic pain

Ryzolt (tramadol HCl extended-release tablets), a centrally-acting synthetic opioid analgesic, has been made available by Purdue Pharma for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of pain for an extended period of time.

Ryzolt is available as a once-daily tablet in 100mg, 200mg, and 300mg dosage strengths.